LSU Health Shreveport Awarded $10.5 Million COBRE Grant by NIH

LSU Health Shreveport has been awarded a five-year, $10.5 million Centers of Biomedical Research Excellence (COBRE) grant by the National Institutes of Health.  The current grant raises the total NIH funding to the Pathology Department to $3.7 million in annual funding, which would rank #1 in the state of Louisiana and #41 in the country based on the current rankings.

The NIH’s highly prestigious and sought after COBRE initiative aims to strengthen an institution’s biomedical research infrastructure through the establishment of a thematic multi-disciplinary center.

The Principle Investigator of the project is Dr. Chris Kevil, Vice Chancellor of Research and a professor in the Department of Pathology. Dr. Wayne Orr, Pathology Research Division Director and Director of the Center for Cardiovascular Diseases and Sciences, is the Core Leader for the Redox Molecular Signaling Core.  Other Pathology Department members include Assistant Professor Dr. Shenuarin Bhuiayn, Subcore Leader for the Cardiovascular Phenotyping Subcore, and Dr. Xinggui Shen, Subcore Leader for the Analytical Redox Biology Subcore.

Additional key research personnel include: Dr. Christopher Pattillo, Assistant Professor in the Department of Molecular and Cellular Physiology; Dr. Manikandan Panchatcharam, Assistant Professor in the Department of Cellular Biology and Anatomy; and Dr. Hyung Nam, Assistant Professor in the Department of Pharmacology, Toxicology and Neuroscience.

Dr. Karen Stokes, Assistant Director of the Center for Cardiovascular Diseases and Sciences, and Dr. Andrew Yurochko, a Professor and member of the CCDS Board of Directors, were also instrumental in helping to secure the COBRE grant.

To learn more about the NIH’s COBRE grant click here

Comments are closed.